$MVNC
Marvion Inc.

2024 Q3 Form 10-Q Financial Statement

#000168316824005625 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $390.3K $645.00
YoY Change -86.92% -99.98%
Cost Of Revenue $193.9K $12.50K
YoY Change -93.51% -0.97%
Gross Profit $196.4K -$11.86K
YoY Change -6663.64% -100.31%
Gross Profit Margin 50.32% -1838.45%
Selling, General & Admin $1.098M
YoY Change -26.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.098M
YoY Change -26.59%
Operating Profit -$377.1K -$1.587M
YoY Change -86.64% -77.82%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $612.00 -$127.3K
YoY Change -99.64% -44.07%
Pretax Income -$376.4K -$1.714M
YoY Change -85.81% -76.78%
Income Tax $2.531K $0.00
% Of Pretax Income
Net Earnings -$379.0K -$1.714M
YoY Change -85.72% -76.78%
Net Earnings / Revenue -97.1% -265747.91%
Basic Earnings Per Share $0.00 -$0.04
Diluted Earnings Per Share $0.00 -$0.04
COMMON SHARES
Basic Shares Outstanding 54.36M shares 53.36M shares
Diluted Shares Outstanding 167.5M shares 38.34M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $393.9K
YoY Change -57.07%
Cash & Equivalents $160.0K $7.177K
Short-Term Investments $386.7K
Other Short-Term Assets $10.65K
YoY Change -0.93%
Inventory $7.771M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $387.9K $8.875M
YoY Change -97.69% 112.4%
LONG-TERM ASSETS
Property, Plant & Equipment $752.4K
YoY Change
Goodwill
YoY Change
Intangibles $14.95K
YoY Change -76.36%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.320M $14.95K
YoY Change 1413.3% -94.3%
TOTAL ASSETS
Total Short-Term Assets $387.9K $8.875M
Total Long-Term Assets $3.320M $14.95K
Total Assets $3.708M $8.890M
YoY Change -78.17% 100.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.218K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.623M $21.21M
YoY Change -69.63% 59.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.623M $21.21M
Total Long-Term Liabilities
Total Liabilities $9.902M $21.21M
YoY Change -65.13% 59.03%
SHAREHOLDERS EQUITY
Retained Earnings -$6.227M -$53.99M
YoY Change -83.06% 58.3%
Common Stock $30.90K $5.336K
YoY Change -99.78% -98.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.195M -$12.32M
YoY Change
Total Liabilities & Shareholders Equity $3.708M $8.890M
YoY Change -78.17% 100.19%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$379.0K -$1.714M
YoY Change -85.72% -76.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
dei Entity Address Address Line1
EntityAddressAddressLine1
21st Floor
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Address Address Line2
EntityAddressAddressLine2
Centennial Tower
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123991 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
10648 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
667287 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
702093 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9274019 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40605 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
179110 usd
CY2023Q4 us-gaap Assets
Assets
9453129 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
15334410 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2154106 usd
CY2023Q4 MVNC Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
1987162 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
170000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19645694 usd
CY2023Q4 us-gaap Liabilities
Liabilities
19645694 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5060 usd
CY2023Q4 MVNC Common Stock To Be Issued
CommonStockToBeIssued
276 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41639772 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1733 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-10192565 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9453129 usd
CY2024Q2 us-gaap Revenues
Revenues
645 usd
CY2023Q2 us-gaap Revenues
Revenues
3858012 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2024Q1 MVNC Fractional Shares Per Reverse Split
FractionalSharesPerReverseSplit
usd
CY2024Q2 MVNC Fractional Shares Per Reverse Split
FractionalSharesPerReverseSplit
usd
CY2023Q2 MVNC Shares Issued Under Share Exchange Agreement In Prior Years
SharesIssuedUnderShareExchangeAgreementInPriorYears
usd
dei Entity Address Country
EntityAddressCountry
SG
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
039190
dei City Area Code
CityAreaCode
65
dei Local Phone Number
LocalPhoneNumber
6829 7029
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54355661 shares
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7177 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
10646 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
7770611 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7770000 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
386684 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
699704 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
8874822 usd
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
138505 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14953 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
15271193 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3614412 usd
CY2024Q2 MVNC Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
2152080 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
170000 usd
CY2024Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
16 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
16 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
21207701 usd
CY2024Q2 us-gaap Liabilities
Liabilities
21207701 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000000 shares
CY2024Q2 MVNC Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
18999999 shares
CY2023Q4 MVNC Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
18999999 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
270000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
270000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54355661 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54355661 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50596157 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50596157 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5336 usd
CY2024Q2 MVNC Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
0 shares
CY2023Q4 MVNC Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
2764009 shares
CY2024Q2 MVNC Common Stock To Be Issued
CommonStockToBeIssued
0 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
41639772 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22385 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53986457 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51840444 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-12317926 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8889775 usd
us-gaap Revenues
Revenues
93234 usd
us-gaap Revenues
Revenues
5557710 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
12503 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
12626 usd
us-gaap Cost Of Revenue
CostOfRevenue
82660 usd
us-gaap Cost Of Revenue
CostOfRevenue
1414743 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
-11858 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
3845386 usd
us-gaap Gross Profit
GrossProfit
10574 usd
us-gaap Gross Profit
GrossProfit
4142967 usd
CY2024Q2 us-gaap Development Costs
DevelopmentCosts
227894 usd
CY2023Q2 us-gaap Development Costs
DevelopmentCosts
7652739 usd
us-gaap Development Costs
DevelopmentCosts
254872 usd
us-gaap Development Costs
DevelopmentCosts
7786868 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
443930 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
892340 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
447160 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1082989 usd
CY2024Q2 us-gaap Business Development
BusinessDevelopment
249000 usd
CY2023Q2 us-gaap Business Development
BusinessDevelopment
1851000 usd
us-gaap Business Development
BusinessDevelopment
249000 usd
us-gaap Business Development
BusinessDevelopment
1896000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
654127 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
603472 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
785672 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1048533 usd
CY2024Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1 usd
CY2023Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-23 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-23 usd
CY2024Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1574952 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10999574 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1736705 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11814413 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1586810 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7154188 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1726131 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7671446 usd
CY2024Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
-0 usd
CY2023Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
57611 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
138505 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
57611 usd
CY2024Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-126614 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-170003 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-280603 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-170003 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
650 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
774 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-0 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
55 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
318 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-127264 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-227559 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-419882 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-227296 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1714074 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7381747 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2146013 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7898742 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1714074 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7381747 usd
us-gaap Net Income Loss
NetIncomeLoss
-2146013 usd
us-gaap Net Income Loss
NetIncomeLoss
-7898742 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4358 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
22097 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
20652 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
24934 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1709716 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7359650 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2125361 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7873808 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.65
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38337971 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1032261 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96634911 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1032261 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38337971 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1032261 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96634911 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1032261 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-10192565 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
16294 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-431939 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-10608210 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4358 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1714074 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-12317926 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1999145 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2837 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-516995 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2513303 usd
CY2023Q2 MVNC Shares Issued As Commitment Shares
SharesIssuedAsCommitmentShares
80400 usd
CY2023Q2 MVNC Shares Issued Under Share Swap Agreement
SharesIssuedUnderShareSwapAgreement
897613 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
22097 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7381747 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8894940 usd
us-gaap Net Income Loss
NetIncomeLoss
-2146013 usd
us-gaap Net Income Loss
NetIncomeLoss
-7898742 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24377 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24992 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
138505 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
57611 usd
MVNC Written Off Intangible Assets
WrittenOffIntangibleAssets
0 usd
MVNC Written Off Intangible Assets
WrittenOffIntangibleAssets
5434 usd
MVNC Digital Assets Received As Revenue
DigitalAssetsReceivedAsRevenue
-0 usd
MVNC Digital Assets Received As Revenue
DigitalAssetsReceivedAsRevenue
5418542 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
23 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-280603 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-170003 usd
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
0 usd
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
5417972 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
611 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1387500 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
382 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
193719 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-60015 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1514484 usd
MVNC Accrued Consulting And Service Fee
AccruedConsultingAndServiceFee
1463387 usd
MVNC Accrued Consulting And Service Fee
AccruedConsultingAndServiceFee
4700859 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1265 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-300149 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-233390 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
160000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
183457 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
162222 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
183457 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
322222 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-122 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1746 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-116814 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
90578 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123991 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99274 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7177 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189852 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
MVNC Shares Issued Under Share Swap Agreement In Exchange Of Marketable Securities
SharesIssuedUnderShareSwapAgreementInExchangeOfMarketableSecurities
0 usd
MVNC Shares Issued Under Share Swap Agreement In Exchange Of Marketable Securities
SharesIssuedUnderShareSwapAgreementInExchangeOfMarketableSecurities
897613 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zMn20pkY4si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86C_zecMfNOKW2L4">Use of estimates and assumptions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparing these unaudited condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates. If actual results significantly differ from the Company’s estimates, the Company’s financial condition and results of operations could be materially impacted. Significant estimates in the period include the impairment loss on digital assets, valuation and useful lives of intangible assets and deferred tax valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
138505 usd
us-gaap Net Income Loss
NetIncomeLoss
-2146013 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53986457 usd
CY2024Q2 us-gaap Revenues
Revenues
645 usd
CY2023Q2 us-gaap Revenues
Revenues
3858012 usd
us-gaap Revenues
Revenues
93234 usd
us-gaap Revenues
Revenues
5557710 usd
CY2024Q2 us-gaap Revenues
Revenues
645 usd
CY2023Q2 us-gaap Revenues
Revenues
3858012 usd
us-gaap Revenues
Revenues
93234 usd
us-gaap Revenues
Revenues
5557710 usd
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
386684 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
667287 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
699704 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
702093 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
154433 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
158336 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-139480 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-117731 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14953 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40605 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
12890 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
403 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
311 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
311 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
311 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
727 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14953 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12503 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12436 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24377 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24992 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3614412 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2154106 usd
CY2024Q2 MVNC Amounts Due To Related Parties
AmountsDueToRelatedParties
2152080 usd
CY2023Q4 MVNC Amounts Due To Related Parties
AmountsDueToRelatedParties
1987162 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
270000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
270000000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
995207 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54355661 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54355661 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50596157 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50596157 shares
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1714074 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7381747 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2146013 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7898742 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38337971 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1032261 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96634911 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1032261 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38337971 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1032261 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96634911 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1032261 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.65
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.65
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38337971 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1032261 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96634911 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1032261 shares
CY2024Q2 MVNC Common Stock Shares Subscribed But Unissued1
CommonStockSharesSubscribedButUnissued1
0 shares
CY2023Q2 MVNC Common Stock Shares Subscribed But Unissued1
CommonStockSharesSubscribedButUnissued1
46156239 shares
MVNC Common Stock Shares Subscribed But Unissued1
CommonStockSharesSubscribedButUnissued1
0 shares
MVNC Common Stock Shares Subscribed But Unissued1
CommonStockSharesSubscribedButUnissued1
46156239 shares
CY2024Q2 MVNC Weighted Average Number Of Diluted Shares Outstanding If Converted
WeightedAverageNumberOfDilutedSharesOutstandingIfConverted
38337971 shares
CY2023Q2 MVNC Weighted Average Number Of Diluted Shares Outstanding If Converted
WeightedAverageNumberOfDilutedSharesOutstandingIfConverted
47188500 shares
MVNC Weighted Average Number Of Diluted Shares Outstanding If Converted
WeightedAverageNumberOfDilutedSharesOutstandingIfConverted
96634911 shares
MVNC Weighted Average Number Of Diluted Shares Outstanding If Converted
WeightedAverageNumberOfDilutedSharesOutstandingIfConverted
47188500 shares
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2146013 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7898742 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37721866 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6412717 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6730369 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6412370 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6730369 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6412370 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q2 us-gaap Investments
Investments
20000000 usd
CY2024Q2 us-gaap Contractual Obligation
ContractualObligation
19743350 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001683168-24-005625-index-headers.html Edgar Link pending
0001683168-24-005625-index.html Edgar Link pending
0001683168-24-005625.txt Edgar Link pending
0001683168-24-005625-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_006.jpg Edgar Link pending
image_007.jpg Edgar Link pending
image_008.jpg Edgar Link pending
image_010.jpg Edgar Link pending
image_014.jpg Edgar Link pending
image_015.jpg Edgar Link pending
image_016.jpg Edgar Link pending
marvion_ex0303.htm Edgar Link pending
marvion_ex0304.htm Edgar Link pending
marvion_ex21.htm Edgar Link pending
marvion_ex3101.htm Edgar Link pending
marvion_ex3102.htm Edgar Link pending
marvion_ex3201.htm Edgar Link pending
marvion_ex3202.htm Edgar Link pending
marvion_i10q-063024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mvnc-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
mvnc-20240630_cal.xml Edgar Link unprocessable
mvnc-20240630_def.xml Edgar Link unprocessable
mvnc-20240630_lab.xml Edgar Link unprocessable
mvnc-20240630_pre.xml Edgar Link unprocessable
marvion_i10q-063024_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending